This study is a non-intervention, multicenter study to address biomarkers of acetaminophen toxicity in children. Specifically, the study will examine acetaminophen (APAP) protein adducts and markers of liver injury in the blood samples of hospitalized children and adolescents who are receiving standard doses of acetaminophen, and children and adolescents who are status post acetaminophen overdose. Ultimately, the data generated from this study will be used to establish second generation biomarkers of acetaminophen toxicity, based on specific adduct proteins, which can be used in future risk assessment studies of children receiving acetaminophen.
Study Type
OBSERVATIONAL
Enrollment
253
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's National Medical Center
Washington D.C., District of Columbia, United States
Kosair Charities Pediatric Clinical Research Unit University of Louisville
Louisville, Kentucky, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States
Akron Children's Research Center
Akron, Ohio, United States
University of Toledo Health Science Center
Toledo, Ohio, United States
Cook's Children's Health System
Fort Worth, Texas, United States
Baylor College of Medicine - Texas Children's Hospital
Houston, Texas, United States